Hrt Financial LP Rx Sight, Inc. Transaction History

Hrt Financial LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$50.42 - $64.29 $1.14 Million - $1.45 Million	-22,540 Reduced 63.25%	13,094 $787,000
Q1 2024 May 13, 2024	BUY	$35.51 - $57.92 $1.27 Million - $2.06 Million	35,634 New	35,634 $1.84 Million
Q2 2023 Aug 11, 2023	BUY	$16.37 - $28.9 $753,740 - $1.33 Million	46,044 New	46,044 $1.33 Million

225

32.3M

394K

32K

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $1.24B
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.